Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Turf war erupts over mRNA

 Posted 5 May 2021 PM

A turf war is set to explode between NSW and Victoria with both states vying to become the epicentre of mRNA manufacturing in Australia. 

Victoria was first out of the blocks, with the government announcing less than two weeks ago it would put up $50 million dollars to kick-start mRNA vaccine and therapeutic manufacturing in Melbourne.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Pharma face-slapped for success
Reputation is finding itself under threat again
Approvals Action
Low dose Symdeko ticked
Along with one generic drug
Special Report
March 2021 PBAC outcomes
Less than a quarter of major new listing requests recommended